USD 0.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | 5329.84 | 6230.51 | 4775.74 |
Gross Profit | - | - | - | -5329.84 | -6230.51 | -4775.74 |
Operating Expenses | 2.31 Million | 2.6 Million | 1.79 Million | 3.08 Million | 1.98 Million | 2.15 Million |
Selling, General and Administrative Expenses | 2.31 Million | 2.6 Million | 1.79 Million | 3.08 Million | 1.98 Million | 2.15 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 2.31 Million | 2.6 Million | 1.79 Million | 3.08 Million | 1.98 Million | 2.15 Million |
Operating Income | -2.25 Million | -2.6 Million | -1.79 Million | -3.08 Million | -1.98 Million | -2.15 Million |
Interest Expense | - | - | - | 104 Thousand | 803 Thousand | 1.22 Million |
Income Tax Expense | 57.6 Thousand | 408 Thousand | -584 Thousand | -1297.00 | -170.86 Thousand | -160.14 Thousand |
Earnings before Tax | -2.39 Million | -2.6 Million | -1.79 Million | -2.66 Million | -2.32 Million | -3.3 Million |
Net Income | -9.64 Million | -3.01 Million | -1.2 Million | -2.66 Million | -2.32 Million | -3.3 Million |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
Weighted Average Shares Outstanding | 1.39 Billion | 1.39 Billion | 1.37 Billion | 1.07 Billion | 735.84 Million | 656.55 Million |
Weighted Average Shares Outstanding (Diluted) | 1.39 Billion | 1.39 Billion | 1.37 Billion | 1.07 Billion | 735.84 Million | 656.55 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | -1.94 Million | -1.51 Million | -2.72 Million | -1.98 Million | -2.15 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 10.11 Thousand | - | - | - | - | - |
Gross Profit | -10.11 Thousand | - | - | - | - | - |
Operating Expenses | 1264.11 | 1261.88 | 211.00 | 2.39 Million | 211.00 | 2.02 Million |
Selling, General and Administrative Expenses | 189.61 Thousand | 189.28 Thousand | 145.00 | - | 145.00 | 2.02 Million |
Research and Development Expenses | 94.82 Thousand | - | - | - | - | - |
Other Expenses | -188.35 Thousand | -188.01 Thousand | -1.96 Million | - | - | - |
Cost and Expenses | 1264.11 | 1261.88 | 211.00 | 2.39 Million | 211.00 | 2.02 Million |
Operating Income | -1264.11 | -1261.88 | -145.00 | -2.25 Million | -145.00 | -2.02 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -188.35 Thousand | -188.01 Thousand | 1195.50 | 2.39 Million | 1195.50 | 260.41 Thousand |
Earnings before Tax | -8216.72 | -8202.20 | -211.00 | -2.39 Million | -211.00 | -2.02 Million |
Net Income | -8216.72 | -8202.20 | -1406.50 | -4.78 Million | -1406.50 | -2.28 Million |
Earnings Per Share Basic | - | -0.00 | - | - | - | -0.01 |
Earnings Per Share Diluted | - | -0.00 | - | - | - | -0.01 |
Weighted Average Shares Outstanding | 6.08 Billion | 6.08 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion |
Weighted Average Shares Outstanding (Diluted) | 6.07 Billion | 6.07 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -184.56 Thousand | -184.23 Thousand | -66.00 | - | -66.00 | -2.02 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
000949
000917
MEDINOV
002712
SWASTIKA
EGG